Sign In

Login

Password

Forgot Password ? Sign Up

Josep Baselga (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Josep Baselga" in German language version.

refsWebsite
Global rank German rank
9zdb-katalog.de
123rd place
6th place
6nytimes.com
7th place
19th place
5web.archive.org
1st place
1st place
2doi.org
2nd place
3rd place
1josebaselga.com
low place
low place
1healio.com
low place
low place
1asklepios.com
low place
low place
1nih.gov
4th place
7th place
1oncotarget.com
low place
low place
1gencat.cat
1,706th place
7,927th place
1ub.edu
4,184th place
low place
1concordia.net
low place
low place
1aacr.org
low place
low place
1reuters.com
49th place
151st place
1lavanguardia.com
377th place
1,373rd place
1nature.com
234th place
203rd place
1esmo.org
low place
low place
1theatlantic.com
228th place
655th place
1youtube.com
9th place
9th place

aacr.org

  • Officers. In: American Association for Cancer Research (AACR). Abgerufen am 31. Mai 2023 (englisch).

asklepios.com

concordia.net

doi.org

  • Wing-yin Leung, Ioannis Roxanis, Helen Sheldon, Francesca M. Buffa, Ji-Liang Li, Adrian L. Harris, Anthony Kong: Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer. In: Oncotarget. Band 6, Nr. 8, 21. Januar 2015, ISSN 1949-2553, S. 5678–5694, doi:10.18632/oncotarget.3296 (oncotarget.com [abgerufen am 31. Mai 2023]).
  • Maurizio Scaltriti: José Baselga 1959–2021. In: Nature Cancer. Band 2, Nr. 5, Mai 2021, ISSN 2662-1347, S. 479–480, doi:10.1038/s43018-021-00209-5 (nature.com [abgerufen am 31. Mai 2023]).

esmo.org

gencat.cat

presidencia.gencat.cat

healio.com

josebaselga.com

lavanguardia.com

  • Muere el oncólogo Josep Baselga, pionero de las terapias personalizadas del cáncer. In: La Vanguardia. (lavanguardia.com [abgerufen am 31. Mai 2023]).

nature.com

nih.gov

ncbi.nlm.nih.gov

  • J. Baselga, D. Tripathy, J. Mendelsohn, S. Baughman, C. C. Benz, L. Dantis, N. T. Sklarin, A. D. Seidman, C. A. Hudis, J. Moore, P. P. Rosen, T. Twaddell, I. C. Henderson, L. Norton: Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. In: Seminars in Oncology. Band 26, 4 Suppl 12, August 1999, ISSN 0093-7754, S. 78–83, PMID 10482197.

nytimes.com

  • Katie Thomas, Charles Ornstein: Top Sloan Kettering Cancer Doctor Resigns After Failing to Disclose Industry Ties. In: The New York Times. 14. September 2018, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Katie Thomas: José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61. In: The New York Times. 26. März 2021, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Katie Thomas: José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61. In: The New York Times. 26. März 2021, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Katie Thomas: José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61. In: The New York Times. 26. März 2021, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Charles Ornstein, Katie Thomas: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals. In: The New York Times. 8. September 2018, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Charles Ornstein, Katie Thomas: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals. In: The New York Times. 8. September 2018, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).

oncotarget.com

  • Wing-yin Leung, Ioannis Roxanis, Helen Sheldon, Francesca M. Buffa, Ji-Liang Li, Adrian L. Harris, Anthony Kong: Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer. In: Oncotarget. Band 6, Nr. 8, 21. Januar 2015, ISSN 1949-2553, S. 5678–5694, doi:10.18632/oncotarget.3296 (oncotarget.com [abgerufen am 31. Mai 2023]).

reuters.com

  • AstraZeneca's head of R&D for oncology dies at 61. In: Reuters. 21. März 2021 (reuters.com [abgerufen am 31. Mai 2023]).

theatlantic.com

ub.edu

web.ub.edu

web.archive.org

youtube.com

zdb-katalog.de

  • Katie Thomas, Charles Ornstein: Top Sloan Kettering Cancer Doctor Resigns After Failing to Disclose Industry Ties. In: The New York Times. 14. September 2018, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Katie Thomas: José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61. In: The New York Times. 26. März 2021, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Katie Thomas: José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61. In: The New York Times. 26. März 2021, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • J. Baselga, D. Tripathy, J. Mendelsohn, S. Baughman, C. C. Benz, L. Dantis, N. T. Sklarin, A. D. Seidman, C. A. Hudis, J. Moore, P. P. Rosen, T. Twaddell, I. C. Henderson, L. Norton: Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. In: Seminars in Oncology. Band 26, 4 Suppl 12, August 1999, ISSN 0093-7754, S. 78–83, PMID 10482197.
  • Wing-yin Leung, Ioannis Roxanis, Helen Sheldon, Francesca M. Buffa, Ji-Liang Li, Adrian L. Harris, Anthony Kong: Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer. In: Oncotarget. Band 6, Nr. 8, 21. Januar 2015, ISSN 1949-2553, S. 5678–5694, doi:10.18632/oncotarget.3296 (oncotarget.com [abgerufen am 31. Mai 2023]).
  • Katie Thomas: José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61. In: The New York Times. 26. März 2021, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Charles Ornstein, Katie Thomas: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals. In: The New York Times. 8. September 2018, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Charles Ornstein, Katie Thomas: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals. In: The New York Times. 8. September 2018, ISSN 0362-4331 (nytimes.com [abgerufen am 31. Mai 2023]).
  • Maurizio Scaltriti: José Baselga 1959–2021. In: Nature Cancer. Band 2, Nr. 5, Mai 2021, ISSN 2662-1347, S. 479–480, doi:10.1038/s43018-021-00209-5 (nature.com [abgerufen am 31. Mai 2023]).